Skip to main content
Skip to main menu
Skip to user menu
Login
|
Employer Login
News
Clinical Research
Finance
Covid-19
See all news
Jobs
Search jobs
Job alerts
Hotbeds
Biotech Bay
Genetown
Biotech Beach
BioMidwest
Pharm Country
See all regions
Career Resources
Interviews
Job search strategy
Resumes & cover letters
Events
Newsletters
Company Profiles
Advertise
Biotech Bay
Biotech Beach
BioCapital
BioMidwest
Bio NC
BioForest
Genetown
Best Places to Work
Pharm Country
Lone Star Bio
NextGen Bio
The Home of the Life Sciences Industry
FDA AdComm Sets Date to Assess GSK’s Plans for Jemperli in Rectal Cancer
The FDA has set a Feb. 9 meeting for its Oncologic Drugs Advisory Committee (ODAC) to discuss whether GSK’s clinical development plans for Jemperli.
Vertex Gives Update on Next-in-Class CF Therapy Amid Demand for Generics
Amid growing demands for generic versions of Vertex’s Trikafta, the company provided an update on the late-stage clinical development of its next-in-class triple combination for cystic fibrosis.
Novel Alliance Responds to Big Pharma's Most Pressing AI/ML Needs
FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits
Advances in Genome Sequencing could Further Precision Cancer Therapies
Search Life Sciences Jobs:
Keywords
Location
More Top Stories
Dragonfly Welcomes BMS-Dropped IL-12 Asset Back into the Fold (Upda...
GEN2 NASH Therapies Near the Finish Line
Roche Goes Toe-to-Toe with AstraZeneca’s Soliris in PNH
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
Biogen’s $1.5B Bet for Depressive Disorders Heads to FDA (Updated)
View more news
Now Hiring
>
>
View all Featured Employers
Careers
Signs Layoffs may be Coming Soon at Your Job
Confidentiality Agreements and Severance Pay: a Comprehensive Guide
BioSpace Layoff Tracker 2023: Eisai, Vyant Bio, Medicago and More Cut Staff
In case you missed it
2/7/2023
Dragonfly Welcomes BMS-Dropped IL-12 Asset Back into the Fold (Updated)
2/7/2023
GEN2 NASH Therapies Near the Finish Line
2/7/2023
Roche Goes Toe-to-Toe with AstraZeneca’s Soliris in PNH
2/7/2023
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
2/6/2023
Biogen’s $1.5B Bet for Depressive Disorders Heads to FDA (Updated)
Hotbeds
>
>
View all Hotbeds
Clinical Research
2/8/2023
FDA AdComm Sets Date to Assess GSK’s Plans for Jemperli in Rectal Cancer
2/8/2023
Vertex Gives Update on Next-in-Class CF Therapy Amid Demand for Generics
2/7/2023
Dragonfly Welcomes BMS-Dropped IL-12 Asset Back into the Fold (Updated)
2/7/2023
GEN2 NASH Therapies Near the Finish Line
Finance
Vertex Gives Update on Next-in-Class CF Therapy Amid Demand for Generics
Signs Layoffs may be Coming Soon at Your Job
Covid-19
Axcella Clears Regulatory Path for Long COVID Therapeutic (Updated)
NeoCart's Revival Continues as FDA Approves Ocugen's Phase III Trial Design (Updated)
Women in Life Sciences
The Black Employee Experience
US Life Sciences Salary Report
Best Places to Work in Biopharma